Search research articles
Contact Us
Filters
Showing results (121-130 of 297) with videos related to
Page
of 30
Sort By:
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
June 11, 2014
Nebulized medications for the treatment of dyspnea: a literature review
Jackelyn Y Boyden, Stephen R Connor, Lily Otolorin, et al.
Chest
|
May 22, 2017
Ventricular Diastolic Pressure Ratio as a Marker of Treatment Response in Pulmonary Hypertension
Arun Jose, Christopher S King, Oksana A Shlobin, et al.
Lung
|
January 22, 2025
Performance of the FORD Versus Other Available Models for the Noninvasive Prediction of Pulmonary Hypertension in Patients with Interstitial Lung Disease
Ho Cheol Kim, Abhimanyu Chandel, Christopher S King, et al.
Advances in Therapy
|
September 11, 2019
Correction to: Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Marilyn K Glassberg, Steven D Nathan, Chin-Yu Lin, et al.
The American Journal of Pathology
|
February 10, 2015
Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosis
Varvara Kirillov, Jonathan T Siler, Mahalakshmi Ramadass, et al.
Chest
|
March 10, 2017
The Diagnosis and Management of Airway Complications Following Lung Transplantation
Amit K Mahajan, Erik Folch, Sandeep J Khandhar, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention
|
January 10, 2019
Left Ventricular Function Before and After Aerobic Exercise Training in Women With Pulmonary Arterial Hypertension
Joshua G Woolstenhulme, Andrew A Guccione, Jeffrey E Herrick, et al.
Chest
|
July 17, 2012
Dynamic patient counseling: a novel concept in idiopathic pulmonary fibrosis
A Whitney Brown, Oksana A Shlobin, Nargues Weir, et al.
BMJ Open Respiratory Research
|
December 25, 2025
Design of the MIST study: a double-blind, randomised, placebo-controlled phase 2b trial of pirfenidone solution for inhalation in patients with progressive pulmonary fibrosis
Martin Kolb, Tamera J Corte, Jeremy Feldman, et al.
Chest
|
May 24, 2013
Glucose transporter-1 distribution in fibrotic lung disease: association with [¹⁸F]-2-fluoro-2-deoxyglucose-PET scan uptake, inflammation, and neovascularization
Souheil El-Chemaly, Daniela Malide, Jianhua Yao, et al.
Page
of 30
Search research articles
Search
Showing results (121-130 of 297) with videos related to
Sort By:
Page
of 30
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
June 11, 2014
Nebulized medications for the treatment of dyspnea: a literature review
Jackelyn Y Boyden, Stephen R Connor, Lily Otolorin, et al.
Chest
|
May 22, 2017
Ventricular Diastolic Pressure Ratio as a Marker of Treatment Response in Pulmonary Hypertension
Arun Jose, Christopher S King, Oksana A Shlobin, et al.
Lung
|
January 22, 2025
Performance of the FORD Versus Other Available Models for the Noninvasive Prediction of Pulmonary Hypertension in Patients with Interstitial Lung Disease
Ho Cheol Kim, Abhimanyu Chandel, Christopher S King, et al.
Advances in Therapy
|
September 11, 2019
Correction to: Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Marilyn K Glassberg, Steven D Nathan, Chin-Yu Lin, et al.
The American Journal of Pathology
|
February 10, 2015
Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosis
Varvara Kirillov, Jonathan T Siler, Mahalakshmi Ramadass, et al.
Chest
|
March 10, 2017
The Diagnosis and Management of Airway Complications Following Lung Transplantation
Amit K Mahajan, Erik Folch, Sandeep J Khandhar, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention
|
January 10, 2019
Left Ventricular Function Before and After Aerobic Exercise Training in Women With Pulmonary Arterial Hypertension
Joshua G Woolstenhulme, Andrew A Guccione, Jeffrey E Herrick, et al.
Chest
|
July 17, 2012
Dynamic patient counseling: a novel concept in idiopathic pulmonary fibrosis
A Whitney Brown, Oksana A Shlobin, Nargues Weir, et al.
BMJ Open Respiratory Research
|
December 25, 2025
Design of the MIST study: a double-blind, randomised, placebo-controlled phase 2b trial of pirfenidone solution for inhalation in patients with progressive pulmonary fibrosis
Martin Kolb, Tamera J Corte, Jeremy Feldman, et al.
Chest
|
May 24, 2013
Glucose transporter-1 distribution in fibrotic lung disease: association with [¹⁸F]-2-fluoro-2-deoxyglucose-PET scan uptake, inflammation, and neovascularization
Souheil El-Chemaly, Daniela Malide, Jianhua Yao, et al.
Page
of 30